These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33242829)

  • 1. Tools for the targeted genetic modification of poxvirus genomes.
    Matía A; Lorenzo MM; Blasco R
    Curr Opin Virol; 2020 Oct; 44():183-190. PubMed ID: 33242829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia and other poxvirus expression vectors.
    Moss B
    Curr Opin Biotechnol; 1992 Oct; 3(5):518-22. PubMed ID: 1368937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines.
    Tang N; Zhang Y; Shen Z; Yao Y; Nair V
    CRISPR J; 2021 Aug; 4(4):477-490. PubMed ID: 34406035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poxvirus vectors: cytoplasmic expression of transferred genes.
    Moss B
    Curr Opin Genet Dev; 1993 Feb; 3(1):86-90. PubMed ID: 8453278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.
    Conrad SJ; Liu J
    Methods Mol Biol; 2019; 1937():189-209. PubMed ID: 30706397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poxvirus cancer therapy.
    Gilbert PA; McFadden G
    Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):309-21. PubMed ID: 18221156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poxvirus-based vectors as vaccine candidates.
    Tartaglia J; Pincus S; Paoletti E
    Crit Rev Immunol; 1990; 10(1):13-30. PubMed ID: 2407263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
    Paoletti E; Taylor J; Meignier B; Meric C; Tartaglia J
    Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Poxviruses: Versatile Tools for Immunological Assays.
    Forsyth KS; Addison MM; Eisenlohr LC
    Methods Mol Biol; 2019; 1988():217-248. PubMed ID: 31147943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy with poxvirus vectors.
    Moroziewicz D; Kaufman HL
    Curr Opin Mol Ther; 2005 Aug; 7(4):317-25. PubMed ID: 16121697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C; Sanda MG
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selectable and excisable marker system for the rapid creation of recombinant poxviruses.
    Rintoul JL; Wang J; Gammon DB; van Buuren NJ; Garson K; Jardine K; Barry M; Evans DH; Bell JC
    PLoS One; 2011; 6(9):e24643. PubMed ID: 21931792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative-strand RNA viruses: applications to biotechnology.
    García-Sastre A
    Trends Biotechnol; 1998 May; 16(5):230-5. PubMed ID: 9621463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poxvirus-based vectors as vaccine candidates.
    Pincus S; Tartaglia J; Paoletti E
    Biologicals; 1995 Jun; 23(2):159-64. PubMed ID: 7546658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing poxvirus vectors vaccine immunogenicity.
    García-Arriaza J; Esteban M
    Hum Vaccin Immunother; 2014; 10(8):2235-44. PubMed ID: 25424927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The uses of poxviruses as vectors.
    Vanderplasschen A; Pastoret PP
    Curr Gene Ther; 2003 Dec; 3(6):583-95. PubMed ID: 14683453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poxvirus genome evolution by gene gain and loss.
    Hughes AL; Friedman R
    Mol Phylogenet Evol; 2005 Apr; 35(1):186-95. PubMed ID: 15737590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poxvirus Safety Analysis in the Pregnant Mouse Model, Vaccinia, and Raccoonpox Viruses.
    Roper RL
    Methods Mol Biol; 2017; 1581():121-129. PubMed ID: 28374246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel poxviruses with unusual genome rearrangements: NY_014 and Murmansk.
    Smithson C; Meyer H; Gigante CM; Gao J; Zhao H; Batra D; Damon I; Upton C; Li Y
    Virus Genes; 2017 Dec; 53(6):883-897. PubMed ID: 28762208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.